Metabolically 'healthy' obesity still linked to higher risk of cardiovascular disease

May 30, 2018

Women who are obese and who have been metabolically healthy for decades are still at higher risk of developing cardiovascular disease compared to metabolically healthy women of normal weight, according to an observational study that followed over 90000 American women for up to 30 years, published in The Lancet Diabetes & Endocrinology journal.

The findings indicate that obesity is a risk factor for cardiovascular disease, regardless of whether or not women develop any of the common metabolic diseases such as high blood pressure or type 2 diabetes.

The study also found that the majority of metabolically healthy women are likely to become metabolically unhealthy over time, even if they were normal weight.

"Our large cohort study confirms that metabolically healthy obesity is not a harmless condition, and even women who remain free of metabolic diseases for decades face an increased risk of cardiovascular events," explains Professor Matthias Schulze from the German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany, who led the research. [1]

"What's more, we observed that most healthy women are likely to develop type 2 diabetes, high blood pressure, or high cholesterol over time, irrespective of their BMI, putting them at much higher risk for cardiovascular disease." [1]

Obesity (BMI of more than 30kg/m²) affects almost all of the cardiovascular disease risk factors, particularly those related to metabolic syndrome including high blood pressure, poor blood sugar control or diabetes, and abnormal blood fats, which double the risk of cardiovascular disease such as heart attacks and stroke. However, some people with obesity seem to be free of these metabolic abnormalities - estimates suggest as many as a third of obese people might be metabolically healthy.

Whether this so called 'metabolically health obesity' is associated with a higher risk of cardiovascular disease has been hotly debated for many years. It remains unclear how changes or maintenance of metabolic status affect the development of cardiovascular disease in both normal weight and overweight/obese individuals.

To investigate this further, Schulze and colleagues examined the association between obesity and cardiovascular disease incidence in 90257 women (initially free from cardiovascular disease) from the Nurses' Health Study - a study tracking the health of female nurses (aged 30-55 years) in the USA since 1976.

Participants were divided into groups by BMI category, metabolic health (defined as the absence of three metabolic risk factors - type 2 diabetes, high blood pressure, and high blood cholesterol), and change in metabolic health status, and followed for 30 years between 1980 and 2010. Participants were sent questionnaires every two years to update their BMI and metabolic health status, as well as to assess their lifestyle, health behaviour, and medical history.

The researchers adjusted for a range of factors that may have influenced the results including age, diet, smoking status, physical activity, alcohol consumption, ethnicity or race, highest education level, menopausal status, aspirin use, and family history of heart attack or diabetes.

During an average follow-up of 24 years, 6306 new cases of cardiovascular disease, including 3304 heart attacks and 3080 strokes were recorded.

Cardiovascular disease risk was especially high in all metabolically unhealthy women, regardless of their BMI. Metabolically unhealthy normal weight women were around 2.5 times more likely to develop cardiovascular disease compared to normal weight women with no metabolic abnormalities, whilst those with 'metabolically healthy obesity' were also at higher risk of cardiovascular disease (39% higher risk) [2].

Importantly, the majority of women who were initially metabolically healthy obese (84%), and around two-thirds (68%) of normal weight metabolically healthy women, converted to unhealthy phenotypes over 20 years.

Furthermore, even women who maintained metabolically healthy obesity over 20 years still had a 57% higher risk of developing cardiovascular disease compared with normal weight metabolically healthy women [3].

"Long-term maintenance of metabolic health is a challenge for overweight/obese, but also for normal-weight women," says Professor Schulze. "Our findings highlight the importance of preventing the development of metabolic diseases, and suggest that even individuals in good metabolic health may benefit from early behavioural management to improve their diet and increase physical activity in order to guard against progression to poor metabolic health." [1]

The authors acknowledge that their findings show observational associations rather than cause and effect. They note some limitations, including that the study included mainly women of European descent, so the findings cannot be generalised to other ethnic groups and men; and that their definition of metabolic health (the absence of three metabolic diseases), may identify a different subgroup than in other studies. However, key strengths include the large cohort, repeated measurements, and long follow up time.

Writing in a linked Comment, Professor Carl Lavie from the University of Queensland School of Medicine, New Orleans, USA and colleagues discuss whether fitness is more important than fatness, pointing out that, "Those with metabolically healthy obesity and decent levels of cardiorespiratory fitness have a quite good overall prognosis from cardiovascular disease and overall survival."

He adds: "Drastic efforts are needed to prevent obesity in the first place and, especially, to prevent conversion to more severe degrees of obesity and the metabolic syndrome. Public health policies aiming to increase cardiorespiratory fitness through physical activity and exercise will further contribute to improve people's health. It is prudent to remind ourselves that an ounce of prevention is better than a pound of cure."
-end-
NOTES TO EDITORS

This study was funded by the US National Institutes of Health, and German Federal Ministry of Education and Research. It was conducted by researchers from German Institute of Human Nutrition Potsdam-Rehbruecke, German Center for Diabetes Research (DZD), University of Potsdam, Harvard T H Chan School of Public Health, Helmholtz Center München at the University of Tübingen, Brigham and Women's Hospital, Harvard Medical School.

[1] Quotes direct from authors and cannot be found in text of Article.

[2] From table 2 - in normal weight women who were metabolically healthy, there were 534 cases of cardiovascular disease during 566689 person-years, equivalent to approximately 0.9 cases in every 1000 person-years.

In normal weight women who were metabolically unhealthy, there were 2036 cases of cardiovascular disease during 490116 person-years, equivalent to approximately 4.2 cases in every 1000 person-years.

In obese women who were metabolically healthy, there were 132 cases of cardiovascular disease during 94562 person-years, equivalent to approximately 1.4 cases in every 1000 person-years.

Note, person-years reflect the total time spent by all individuals in the cohort or a subgroup at risk of developing cardiovascular disease during the study period. For example, 1000 person-years would accumulate if 1000 people were at risk over 1 year of follow-up, or if 100 people were at risk over 10 years.

[3] From table 7 - in normal weight women who remained metabolically healthy over the 20 years, there were 256 cases of cardiovascular disease during 219963 person-years, equivalent to approximately 1.2 cases in every 1000 person-years.

In obese women who remained metabolically healthy over the 20 years, there were 24 cases of cardiovascular disease during 10741 person-years, equivalent to approximately 2.2 cases in every 1000 person-years.

For interviews with article author, Professor Matthias Schulze, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany, please contact: E) mschulze@dife.de T) +49 33200 882434

For interviews with comment please contact Professor Carl Lavie, The John Ochsner Heart and Vascular Institute, University of Queensland School of Medicine, New Orleans, USA E) clavie@oschsner.org T) +1 504 842 1281 (secretary)

For embargoed access to the Article and Comment, please see: http://www.thelancet-press.com/embargo/healthyobesity.pdf

For embargoed access to the Appendix, please see: http://www.thelancet-press.com/embargo/healthyobesityAPPX.pdf

NOTE: THE ABOVE LINK IS FOR JOURNALISTS ONLY; IF YOU WISH TO PROVIDE A LINK FOR YOUR READERS, PLEASE USE THE FOLLOWING, WHICH WILL GO LIVE AT THE TIME THE EMBARGO LIFTS: http://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30137-2/fulltext

The Lancet

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.